The role of EAF2 in leukemia, prostate cancer, colorectal cancer, glioblastoma, and gastric cancer has been identified (Zhuang et al., 2008; Xiao et al., 2008; Sun et al., 2020). Here, EAF2 is linked to prostate carcinoma.